Yosuke Tsukiboshi

Dr. Yosuke Tsukiboshi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2023 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
CLChun‐Teh Lee
Chun‐Teh Lee
DTDuong Tran
Duong Tran
YTYosuke Tsukiboshi
Yosuke Tsukiboshi
SMSeiko Min
Seiko Min
SKSung K. Kim
Sung K. Kim
RWRobin Weltman
Robin Weltman


1 October 2020 in American Journal of Orthodontics and Dentofacial Orthopedics
Verified
Journal Article
Closed access
YTYosuke Tsukiboshi
Yosuke Tsukiboshi
CTChihiro Tanikawa
Chihiro Tanikawa
TYTakashi Yamashiro
Takashi Yamashiro

16 January 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YTYosuke Tsukiboshi
Yosuke Tsukiboshi
ANAzumi Noguchi
Azumi Noguchi
HHHanane Horita
Hanane Horita
YMYurie Mikami
Yurie Mikami
SYSatoshi Yokota
Satoshi Yokota
HYHiroki Yoshioka
Hiroki Yoshioka

7 April 2025 in Plants
Verified
Journal Article
Open access
PDF file
HHHanane Horita
Hanane Horita
YTYosuke Tsukiboshi
Yosuke Tsukiboshi
KOKenichi Ogata
Kenichi Ogata
AOAya Ogata
Aya Ogata
HKHisaka Kurita
Hisaka Kurita
HYHiroki Yoshioka
Hiroki Yoshioka
Cleft palate is a common birth defect worldwide and is caused by both genetic and environmental factors. Intrauterine drug exposure is one of the environmental factors that can induce cleft palate. Mycophenolate mofetil (MPM) is an immunosuppressant drug with teratogenic effects, including cleft palate. However, the research on MPM-induced cleft palate remains limited. Sasa veitchii extract (SE), a medical plant extract, is commercially available in Asia and has been reported to show effectiveness against oral diseases. The purpose of the present study is to evaluate whether SE protects against MPM-induced immunosuppression in human embryonic palatal mesenchymal (HEPM) cells. Cell viability and G1 phase-related cell cycle markers were assessed by co-treatment with MPM and SE. Furthermore, we quantified cleft palate-associated miRNA levels and the expression of its downstream genes. MPM treatment reduced cell viability in a concentration-dependent manner. Co-treatment with SE alleviated MPM-induced inhibition of HEPM cell proliferation. Additionally, SE reduced MPM-induced miR-4680-3p upregulation and the downregulation of its downstream genes (ERBB2 and JADE1). These results suggest that SE alleviated MPM-induced cell proliferation inhibition through modulating miR-4680-3p expression.

6 February 2025 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
HYHiroki Yoshioka
Hiroki Yoshioka
HHHanane Horita
Hanane Horita
YTYosuke Tsukiboshi
Yosuke Tsukiboshi
HKHisaka Kurita
Hisaka Kurita
AOAya Ogata
Aya Ogata
KOKenichi Ogata
Kenichi Ogata
Background/Objectives: Cleft palate is a birth defect associated with environmental and genetic factors. Disturbance of microRNAs (miRNAs) and exposure to medicinal agents during pregnancy can cause cleft palate. Although an association between medicine-induced cleft palate and miRNAs has been suggested, it remains to be fully elucidated. This study aimed to clarify the molecular mechanism underlying mycophenolate mofetil (MPM)-induced inhibition of cell proliferation and miRNA expression in human embryonic palatal mesenchymal (HEPM) cells. Methods: Cell viability, apoptosis, and cell cycle-related markers were evaluated 48 h after MPM treatment. In addition, miRNA levels and expression of their downstream genes were measured, and a rescue experiment was performed using miR-4680-3p and/or let-7c-5p inhibitors. Results: MPM dose-dependently reduced HEPM cell viability. Additionally, MPM treatment suppressed cyclin-D1, cyclin E1, cyclin-dependent kinase (CDK)-2, and CDK6 expression in HEPM cells. Furthermore, MPM upregulated miR-4680-3p and let-7c-5p expression and downregulated the downstream genes of each miRNA. Moreover, miR-4680-3p and/or let-7c-5p inhibitors alleviated MPM-induced inhibition of cell proliferation. Conclusions: These results suggest that MPM-induced cleft palate is associated with miR-4680-3p and let-7c-5p expression in HEPM cells.